Akebia Therapeutics's total assets for Q1 2025 were $310.19M, an increase of 40.57% from the previous quarter. AKBA total liabilities were $285.60M for the fiscal quarter, a 5.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.